Physician profile
Clara Lee
NPI 1881822369
$793.01
in general payments reported to CMS, 2019-2025
16 companies · $133 in 2025
The $133 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $130 · 2021: $107 · 2022: $125 · 2023: $22.37 · 2024: $150 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $232.50 | 2022-2024 | Andexxa |
| Glaxosmithkline, LLC. | $88.14 | 2019-2021 | |
| Genentech USA, INC. | $67.37 | 2019-2021 | |
| Pfizer INC. | $60.65 | 2019-2024 | |
| Phadia US INC. | $55.51 | 2020-2025 | Immunocap |
| Optinose US, INC. | $43.20 | 2025 | |
| Cranial Technologies, INC | $38.03 | 2019-2021 | |
| Alk-Abello, INC | $35.31 | 2025 | Neffy, Grastek, Ragwitek |
| Daiichi Sankyo INC. | $29.99 | 2020 | |
| Dermira, INC. | $25.27 | 2020 | |
| Exact Sciences Corporation | $24.55 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $22.37 | 2023 | |
| Csl Behring | $21.93 | 2021 | |
| Invivyd INC | $20.00 | 2025 | Pemgarda |
| Biogen, INC. | $15.06 | 2025 | Skyclarys |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clara Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.